These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11261537)

  • 21. Treatment of Fungal Urinary Tract Infection.
    Thomas L; Tracy CR
    Urol Clin North Am; 2015 Nov; 42(4):473-83. PubMed ID: 26475944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
    Kauffman CA; Vazquez JA; Sobel JD; Gallis HA; McKinsey DS; Karchmer AW; Sugar AM; Sharkey PK; Wise GJ; Mangi R; Mosher A; Lee JY; Dismukes WE
    Clin Infect Dis; 2000 Jan; 30(1):14-8. PubMed ID: 10619726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluconazole in the management of fungal urinary tract infections.
    Voss A; Meis JF; Hoogkamp-Korstanje JA
    Infection; 1994; 22(4):247-51. PubMed ID: 8002084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents.
    Fasano C; O'Keeffe J; Gibbs D
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):351-4. PubMed ID: 8070446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of high dosage fluconazole in therapy of candida infections in intensive care medicine].
    Duswald KH; Pittrow L; Penk A
    Anaesthesiol Reanim; 1998; 23(5):134-8. PubMed ID: 9854332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
    Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluconazole infused via a nephrostomy tube: a novel and effective route of delivery.
    Oliver SE; Walker RJ; Woods DJ
    J Clin Pharm Ther; 1995 Dec; 20(6):317-8. PubMed ID: 8847369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic evaluation of fluconazole in critically ill patients.
    Sinnollareddy M; Peake SL; Roberts MS; Playford EG; Lipman J; Roberts JA
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1431-40. PubMed ID: 21883033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical course of fungal urinary tract infection in neonates].
    Ratajczak B; Wierzba J; Irga N; Czarniak P; Kosiak W; Samet A; Chabior M
    Pediatr Pol; 1996 Apr; 71(4):331-7. PubMed ID: 8975221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
    Osawa K; Shigemura K; Yoshida H; Fujisawa M; Arakawa S
    J Antibiot (Tokyo); 2013 Nov; 66(11):651-4. PubMed ID: 23801184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketoconazole therapy for fungal urinary tract infections.
    Graybill JR; Galgiani JN; Jorgensen JH; Strandberg DA
    J Urol; 1983 Jan; 129(1):68-70. PubMed ID: 6298476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful use of fluconazole for treatment of urinary tract fungal infections.
    Tacker JR
    J Urol; 1992 Dec; 148(6):1917-8. PubMed ID: 1433642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fluconazole treatment of systemic mycoses].
    Mori T; Matsumura M; Ebe T; Takahashi M; Kohara T; Inagaki M; Isonuma H; Hibiya I; Hamamoto T; Watanabe K
    Jpn J Antibiot; 1989 Jan; 42(1):55-62. PubMed ID: 2540368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose fluconazole therapy in patients with severe fungal infections.
    Voss A; de Pauw BE
    Eur J Clin Microbiol Infect Dis; 1999 Mar; 18(3):165-74. PubMed ID: 10357048
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluconazole treatment of children with severe fungal infections not treatable with conventional agents.
    Fasano C; O'Keeffe J; Gibbs D
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):344-7. PubMed ID: 8070444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fungal urinary tract infections in patients at risk.
    Krcmery S; Dubrava M; Krcmery V
    Int J Antimicrob Agents; 1999 May; 11(3-4):289-91. PubMed ID: 10394985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.